DE2510439A1 - Neue organische verbindungen und verfahren zu deren herstellung - Google Patents
Neue organische verbindungen und verfahren zu deren herstellungInfo
- Publication number
- DE2510439A1 DE2510439A1 DE19752510439 DE2510439A DE2510439A1 DE 2510439 A1 DE2510439 A1 DE 2510439A1 DE 19752510439 DE19752510439 DE 19752510439 DE 2510439 A DE2510439 A DE 2510439A DE 2510439 A1 DE2510439 A1 DE 2510439A1
- Authority
- DE
- Germany
- Prior art keywords
- formula
- compounds
- trifluoromethyl
- hydrogen
- thiosemicarbazide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 10
- 238000004519 manufacturing process Methods 0.000 title description 3
- 150000002894 organic compounds Chemical class 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims description 30
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 10
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 7
- 239000000460 chlorine Substances 0.000 claims description 7
- 229910052801 chlorine Inorganic materials 0.000 claims description 7
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 6
- 239000011737 fluorine Substances 0.000 claims description 6
- 239000002841 Lewis acid Substances 0.000 claims description 4
- 150000007517 lewis acids Chemical class 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 150000004867 thiadiazoles Chemical class 0.000 claims description 3
- 239000013256 coordination polymer Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- BRWIZMBXBAOCCF-UHFFFAOYSA-N hydrazinecarbothioamide Chemical compound NNC(N)=S BRWIZMBXBAOCCF-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- -1 phosphorus halide Chemical class 0.000 description 3
- 230000004799 sedative–hypnotic effect Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000000803 paradoxical effect Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- BLXXCCIBGGBDHI-UHFFFAOYSA-N 2-[3-(trifluoromethyl)phenyl]acetic acid Chemical compound OC(=O)CC1=CC=CC(C(F)(F)F)=C1 BLXXCCIBGGBDHI-UHFFFAOYSA-N 0.000 description 1
- 125000006495 3-trifluoromethyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])*)C(F)(F)F 0.000 description 1
- 125000001318 4-trifluoromethylbenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(F)(F)F 0.000 description 1
- MPCUXXOGGPBCMY-UHFFFAOYSA-N 5-[1-[3-(trifluoromethyl)phenyl]propan-2-yl]-1,3,4-thiadiazol-2-amine Chemical compound N=1N=C(N)SC=1C(C)CC1=CC=CC(C(F)(F)F)=C1 MPCUXXOGGPBCMY-UHFFFAOYSA-N 0.000 description 1
- CQGPWMLXDDBWBK-UHFFFAOYSA-N 5-[2-[3-(trifluoromethyl)phenyl]propyl]-1,3,4-thiadiazol-2-amine Chemical compound C=1C=CC(C(F)(F)F)=CC=1C(C)CC1=NN=C(N)S1 CQGPWMLXDDBWBK-UHFFFAOYSA-N 0.000 description 1
- ZXURVTKXEFEZML-UHFFFAOYSA-N 5-[3-[3-(trifluoromethyl)phenyl]propyl]-1,3,4-thiadiazol-2-amine Chemical compound S1C(N)=NN=C1CCCC1=CC=CC(C(F)(F)F)=C1 ZXURVTKXEFEZML-UHFFFAOYSA-N 0.000 description 1
- QHQVBZWCNJVWJZ-UHFFFAOYSA-N 5-[[2,5-dichloro-3-(trifluoromethyl)phenyl]methyl]-1,3,4-thiadiazol-2-amine Chemical compound S1C(N)=NN=C1CC1=CC(Cl)=CC(C(F)(F)F)=C1Cl QHQVBZWCNJVWJZ-UHFFFAOYSA-N 0.000 description 1
- RRXDVGPGAOJOFL-UHFFFAOYSA-N 5-[[3-(trifluoromethyl)phenyl]methyl]-1,3,4-thiadiazol-2-amine Chemical compound S1C(N)=NN=C1CC1=CC=CC(C(F)(F)F)=C1 RRXDVGPGAOJOFL-UHFFFAOYSA-N 0.000 description 1
- JUUVCOHFHWKSSY-UHFFFAOYSA-N 5-[[3-chloro-5-(trifluoromethyl)phenyl]methyl]-1,3,4-thiadiazol-2-amine Chemical compound S1C(N)=NN=C1CC1=CC(Cl)=CC(C(F)(F)F)=C1 JUUVCOHFHWKSSY-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- QVSABOFUEHNNTC-UHFFFAOYSA-N NC=1SC(=NN=1)CC1=CC(=C(C=C1)C(F)(F)F)C(F)(F)F Chemical compound NC=1SC(=NN=1)CC1=CC(=C(C=C1)C(F)(F)F)C(F)(F)F QVSABOFUEHNNTC-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- NSIMQTOXNOFWBP-UHFFFAOYSA-N acetamidothiourea Chemical compound CC(=O)NNC(N)=S NSIMQTOXNOFWBP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45267874A | 1974-03-20 | 1974-03-20 | |
| US05/528,477 US3965110A (en) | 1974-07-05 | 1974-11-29 | 2-Amino-5-(trifluoromethyl phenylalkyl)-1,3,4-thiadiazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2510439A1 true DE2510439A1 (de) | 1975-09-25 |
Family
ID=27036857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19752510439 Pending DE2510439A1 (de) | 1974-03-20 | 1975-03-11 | Neue organische verbindungen und verfahren zu deren herstellung |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS50154251A (en, 2012) |
| CA (1) | CA1050031A (en, 2012) |
| CH (1) | CH593957A5 (en, 2012) |
| DD (1) | DD117463A5 (en, 2012) |
| DE (1) | DE2510439A1 (en, 2012) |
| DK (1) | DK136248B (en, 2012) |
| ES (1) | ES435777A1 (en, 2012) |
| FI (1) | FI750696A7 (en, 2012) |
| FR (1) | FR2264532B2 (en, 2012) |
| GB (1) | GB1482371A (en, 2012) |
| HU (1) | HU169267B (en, 2012) |
| IE (1) | IE40948B1 (en, 2012) |
| IL (2) | IL46860A (en, 2012) |
| NL (1) | NL7503058A (en, 2012) |
| NO (1) | NO750829L (en, 2012) |
| SE (1) | SE404695B (en, 2012) |
| SU (1) | SU645574A3 (en, 2012) |
-
1975
- 1975-03-10 CH CH299775A patent/CH593957A5/xx not_active IP Right Cessation
- 1975-03-11 FI FI750696A patent/FI750696A7/fi not_active Application Discontinuation
- 1975-03-11 SE SE7502708A patent/SE404695B/xx unknown
- 1975-03-11 DK DK98275AA patent/DK136248B/da unknown
- 1975-03-11 DE DE19752510439 patent/DE2510439A1/de active Pending
- 1975-03-12 NO NO750829A patent/NO750829L/no unknown
- 1975-03-14 NL NL7503058A patent/NL7503058A/xx not_active Application Discontinuation
- 1975-03-17 GB GB10987/75A patent/GB1482371A/en not_active Expired
- 1975-03-18 ES ES435777A patent/ES435777A1/es not_active Expired
- 1975-03-18 HU HUSA2761A patent/HU169267B/hu unknown
- 1975-03-18 JP JP50031907A patent/JPS50154251A/ja active Pending
- 1975-03-18 IE IE576/75A patent/IE40948B1/xx unknown
- 1975-03-18 DD DD184853A patent/DD117463A5/xx unknown
- 1975-03-18 CA CA222,445A patent/CA1050031A/en not_active Expired
- 1975-03-18 IL IL46860A patent/IL46860A/en unknown
- 1975-03-18 FR FR7508350A patent/FR2264532B2/fr not_active Expired
- 1975-03-19 SU SU752115292A patent/SU645574A3/ru active
-
1976
- 1976-03-18 IL IL46860*TA patent/IL46860A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE40948B1 (en) | 1979-09-12 |
| FI750696A7 (en, 2012) | 1975-09-21 |
| HU169267B (en, 2012) | 1976-10-28 |
| AU7928975A (en) | 1976-09-23 |
| NL7503058A (nl) | 1975-09-23 |
| CH593957A5 (en, 2012) | 1977-12-30 |
| FR2264532B2 (en, 2012) | 1978-08-04 |
| NO750829L (en, 2012) | 1975-09-23 |
| CA1050031A (en) | 1979-03-06 |
| IE40948L (en) | 1975-09-20 |
| IL46860A0 (en) | 1975-05-22 |
| SU645574A3 (ru) | 1979-01-30 |
| IL46860A (en) | 1977-12-30 |
| FR2264532A2 (en, 2012) | 1975-10-17 |
| GB1482371A (en) | 1977-08-10 |
| DK136248C (en, 2012) | 1978-03-13 |
| DK98275A (en, 2012) | 1975-09-21 |
| ES435777A1 (es) | 1977-07-01 |
| SE404695B (sv) | 1978-10-23 |
| DD117463A5 (en, 2012) | 1976-01-12 |
| DK136248B (da) | 1977-09-12 |
| JPS50154251A (en, 2012) | 1975-12-12 |
| SE7502708L (en, 2012) | 1975-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1595915C3 (de) | Pyrrolidinderivate | |
| DE1300575B (de) | Benzo[b]thiophene | |
| DE2322880C2 (de) | 4-(Imidazolin-2-ylamino)-2,1,3-benzothiadiazole und Verfahren zu deren Herstellung | |
| DE1545932A1 (de) | Verfahren zur Herstellung von Benzothiazepin-Derivaten | |
| DE2233458A1 (de) | Neue chinolinderivate | |
| DE2511891A1 (de) | Neue derivate des 2,6-dioxopiperazins, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel sowie verfahren zu deren herstellung | |
| DE2510439A1 (de) | Neue organische verbindungen und verfahren zu deren herstellung | |
| CH579565A5 (en) | Imidazolin-2-ylamino-2,1,3-benzothiadiazoles prodn. - by cyclising corresp. beta aminoethyl (thio) ureas, active against muscle tremors and rigor | |
| DE2335507C2 (de) | Sulfamylbenzoesäurederivate, Verfahren zu deren Herstellung und sie enthaltendes pharmazeutisches Mittel | |
| DE1770177A1 (de) | Monoaryl-substituierte Oxazole | |
| AT352745B (de) | Verfahren zur herstellung von neuen thienothiazinderivaten | |
| DE1246742B (de) | Verfahren zur Herstellung von neuen Phenothiazinen | |
| DE1252204B (de) | Verfahren zur Herstellung von 2,4-Dinitropyrrolderivaten | |
| AT359492B (de) | Verfahren zur herstellung neuer indazolderivate und ihrer salze | |
| DE2203743A1 (de) | Neue Phenalendiamin-Derivate und Verfahren zu deren Herstellung | |
| DE1620309C3 (de) | Thieno-benzothiazin-Derivat und Verfahren zu seiner Herstellung | |
| EP0021058A2 (de) | Benzothienothiazinderivate, deren Verwendung, Verfahren und Zwischenprodukte zu deren Herstellung und diese enthaltende Arzneimittel | |
| DE1795189A1 (de) | Verfahren zur Herstellung neuer heterocyclischer Verbindungen | |
| AT345838B (de) | Verfahren zur herstellung von neuen tricyclischen verbindungen und ihren saeure- additionssalzen | |
| AT262992B (de) | Verfahren zur Herstellung von neuen Thieno-benzothiazin-Derivaten und ihren Salzen | |
| DE2625195A1 (de) | 1-methyl-2-(4-aminophenyl-substit.- methyl)-5-nitro-imidazole und verfahren zu ihrer herstellung | |
| DE2507818A1 (de) | Neue organische verbindungen und verfahren zu deren herstellung | |
| AT370406B (de) | Verfahren zur herstellung neuer allylaminderivate und ihrer saeureadditionssalze | |
| AT267532B (de) | Verfahren zur Herstellung von neuen 4,5-Dihydrothieno[2,3-b][1,5]benzothiazepin-4-onen und ihren Säureadditionssalzen | |
| CH676847A5 (en, 2012) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHJ | Non-payment of the annual fee |